Breaking News Instant updates and real-time market news.

CRSP

Crispr Therapeutics

$36.62

-0.28 (-0.76%)

07:08
10/15/19
10/15
07:08
10/15/19
07:08

Crispr Therapeutics, KSQ Therapeutics announce license agreement

CRISPR Therapeutics and KSQ Therapeutics announced a license agreement whereby CRISPR Therapeutics will gain access to KSQ intellectual property for editing certain novel gene targets in its allogeneic oncology cell therapy programs, and KSQ will gain access to CRISPR Therapeutics' IP for editing novel gene targets identified by KSQ as part of its current and future eTIL cell programs. The financial terms of the agreement are not being disclosed. The gene targets within the scope of the license agreement were identified using KSQ's proprietary CRISPRomics drug discovery engine, which allows genome-scale, in vivo validated, unbiased drug discovery. These specific targets were uncovered in screens to identify genetic edits that could enhance the functionality and quality of adoptive cell therapies in oncology.

CRSP Crispr Therapeutics
$36.62

-0.28 (-0.76%)

07/30/19
PIPR
07/30/19
NO CHANGE
Target $100
PIPR
Overweight
Piper reiterates $100 price target on Crispr Therapeutics post Q2 results
Crispr Therapeutics ended Q2 with cash of $428M, and when including the $175M Vertex upfront and draw-downs, the company could now hold pro forma cash of ~$656M, Piper Jaffray analyst Edward Tenthoff tells investors in a research note. Crispr announced that the first beta thalassemia patient remains transfusion independent for greater than four months since engraftment, representing the first clinical proof of concept for a CRISPR/Cas9 therapy, adds the analyst. Further, he notes that the first sickle cell disease patient was treated with CTX001 in the U.S. Tenthoff reiterates an Overweight rating on Crispr Therapeutics with a $100 price target.
07/30/19
ROTH
07/30/19
NO CHANGE
Target $65
ROTH
Buy
Crispr Therapeutics price target raised to $65 from $50 at Roth Capital
Roth Capital analyst Tony Butler raised his price target for Crispr Therapeutics to $65 from $50 after the company reported ending Q2 with $427.9M in cash, which is expected to support operations through 2020, and announced that the first TDT patient treated with CTX001 remains transfusion-independent beyond four months and that the FIH trial of CTX110 in NHL was initiated. The analyst reiterates a Buy rating on the shares based on his continued positive outlook.
08/01/19
JEFF
08/01/19
INITIATION
Target $64
JEFF
Buy
Crispr Therapeutics initiated with a Buy at Jefferies
Jefferies analyst Maury Raycroft started Crispr Therapeutics with a Buy rating and $64 price target. The company offers the best CRISPR/Cas9 development risk/reward profile, Raycroft tells investors in a research note. He believes that starting with sickle cell disease and beta-thalassemia will "de-risk" its broader pipeline. Crispr Therapeutics has "made strategically sound and differentiated decisions" that should play out in its favor for the longer term, contends the analyst.
08/01/19
08/01/19
INITIATION

Fly Intel: Top analyst initiations
Catch up on today's top analyst initiations with this list compiled by The Fly: 1. AMD (AMD) and Maxim Integrated (MXIM) initiated with a Hold at Benchmark. 2. Amag Pharmaceuticals (AMAG) and Cassava Sciences (SAVA) initiated with a Buy at H.C. Wainwright. 3. Crispr Therapeutics (CRSP) initiated with a Buy at Jefferies. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

EIDX

Eidos Therapeutics

$55.16

8.58 (18.42%)

, BBIO

BridgeBio

$29.06

0.8 (2.83%)

05:07
11/19/19
11/19
05:07
11/19/19
05:07
Recommendations
Eidos Therapeutics price target raised to $75 from $55 at Piper Jaffray »

Piper Jaffray analyst…

EIDX

Eidos Therapeutics

$55.16

8.58 (18.42%)

BBIO

BridgeBio

$29.06

0.8 (2.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

PHAT

Phathom Pharmaceuticals

$24.88

-1.12 (-4.31%)

05:01
11/19/19
11/19
05:01
11/19/19
05:01
Initiation
Phathom Pharmaceuticals initiated  »

Phathom Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LEG

Leggett & Platt

$53.54

0.18 (0.34%)

04:59
11/19/19
11/19
04:59
11/19/19
04:59
Downgrade
Leggett & Platt rating change  »

Leggett & Platt…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

CSL

Carlisle

$161.08

0.12 (0.07%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Carlisle management to meet with Seaport Global »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

KRP

Kimbell Royalty Partners

$14.18

0.19 (1.36%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Kimbell Royalty Partners management to meet with TD Securities »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

SU

Suncor

$31.84

-0.64 (-1.97%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Suncor management to meet with TD Securities »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

ASML

ASML

$273.38

-1.35 (-0.49%)

, ERIC

Ericsson

$9.10

-0.04 (-0.44%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
JPMorgan to hold a conference »

Global TMT…

ASML

ASML

$273.38

-1.35 (-0.49%)

ERIC

Ericsson

$9.10

-0.04 (-0.44%)

IMAX

Imax

$20.88

-0.19 (-0.90%)

SIMO

Silicon Motion

$42.65

0.03 (0.07%)

SSNLF

Samsung

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

  • 02

    Dec

  • 09

    Dec

  • 09

    Dec

  • 11

    Dec

  • 06

    Jan

ACCO

Acco Brands

$9.42

0.035 (0.37%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Acco Brands management to meet with Barrington »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Stephens business services analyst to hold a group luncheon »

Group Luncheon Meeting to…

CSGS

CSG

$57.54

0.54 (0.95%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
CSG management to meet with Sidoti »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

04:55
11/19/19
11/19
04:55
11/19/19
04:55
General news
Breaking General news story  »

8-Week Bill Announcement…

ADM

Archer Daniels

$42.84

-0.03 (-0.07%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Archer Daniels management to meet with Buckingham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

AHT

Ashford Hospitality

$2.70

-0.005 (-0.19%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Ashford Hospitality management to meet with DA Davidson »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

AMSF

Amerisafe

$65.49

-0.15 (-0.23%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Amerisafe management to meet with B. Riley FBR »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

ESVIF

Ensign Energy

$0.00

(0.00%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Ensign Energy management to meet with TD Securities »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

FC

Franklin Covey

$37.20

-0.3 (-0.80%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Franklin Covey management to meet with Roth Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

PSNL

Personalis

$8.89

-0.85 (-8.73%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Personalis management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

SLNG

Stabilis Energy

$0.00

(0.00%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Stabilis Energy management to meet with Lake Street »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Deutsche Bank to hold a conference »

Japan Consumer &…

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Raymond James to hold a conference »

Growth & Value…

CNR

Cornerstone Building Brands

$6.91

-0.015 (-0.22%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Recommendations
Cornerstone Building Brands analyst commentary  »

Cornerstone Building…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

04:55
11/19/19
11/19
04:55
11/19/19
04:55
General news
Breaking General news story  »

4-Week Bill Announcement…

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Securities Industry & Financial Markets Association to hold annual meeting »

SIFMA Annual Meeting 2019…

DZSI

Dasan Zhone

$7.58

-0.17 (-2.19%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Dasan Zhone management to meet with B. Riley FBR »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

EBSB

Meridian Bancorp

$20.04

0.07 (0.35%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Meridian Bancorp management to meet with Compass Point »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.